Delivery Order SPE2DB22D2206-SPE2DB25FDY01

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 40 mg capsules. The $10,734.40 firm fixed-price contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $3,753.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules, a medication used to treat cardiovascular conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the provision of Carvedilol ER 40 mg capsules to the U.S. government. The contract, valued at $16,506.45, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,315.69, is a Firm Fixed Price Delivery Order for the supply of Carvedilol ER 40 mg capsules. The award has an ultimate completion date of January 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $16,506.31 firm fixed-price delivery order is for the supply of Carvedilol ER 40 mg capsules for military healthcare programs. The contract has an ultimate completion date of November 13, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,166.97 firm fixed-price delivery order is for the supply of Carvedilol ER 40 mg capsules. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $26,787.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Carvedilol ER 80 mg Capsules, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as a...
This federal contract award, valued at $3,848.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 80 mg capsules and has an ultimate completion date of August 2, 2024. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $5,063.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Carvedilol ER 40 mg capsules, a medication used to treat heart conditions. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 40 mg capsules. The $5,462.08 firm-fixed-price delivery order contract has an ultimate completion date of December 7, 2023. The award is not designated under any set-aside program. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant $999,999,999 Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDY01
    Delivery Order

This federal contract award, valued at $6,126.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 40 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of October 25, 2024.

Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has established itself as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award does not have a set-aside designation, indicating open competition.

Generated 1/23/25, 9:41 AM